{"entity":{"id":"modulari-t","kind":"company","name":"Modulari-T","aka":[],"tldr":"Modulari-T designs synthetic genes that let engineered immune cells sense their surroundings and change behaviour, so cell therapies can find and kill cancer more reliably.","summary":"Modulari-T, based in Montreal with a San Francisco presence, has designed a family of synthetic genetic modules that reprogramme cells to sense environmental cues and respond, applied first to engineering T cells and other immune cells that recognise and kill tumour cells more efficiently, with a stated ambition to become a platform for all cell engineering including regenerative medicine. The company is preclinical; no sourced financing rounds are recorded.","asOf":"2026-09-10","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/modulari-t"},{"label":"Official website","url":"https://modularit.bio"}],"tags":["yc"],"related":[],"cancers":[],"sections":["cell-therapy"],"technologies":["armored-car","car-t"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Montreal","country":"CA","companyType":"cell-therapy","website":"https://modularit.bio","stage":"startup","ycBatch":"W23","investors":["y-combinator"],"funding":[]},"route":"/companies/modulari-t/","neighbours":{"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"}],"technology":[{"id":"armored-car","kind":"technology","name":"Armoured, logic-gated & next-gen CARs","route":"/technologies/armored-car/"},{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"company":[{"id":"y-combinator","kind":"company","name":"Y Combinator","route":"/companies/y-combinator/"}]}}